Gabelli Upgrades Assertio Therapeutics (ASRT) to Buy

April 9, 2021 8:09 AM EDT
Get Alerts ASRT Hot Sheet
Price: $1.84 -1.08%

Rating Summary:
    7 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 12 | New: 41
Trade Now! 
Join SI Premium – FREE

Gabelli analyst Kevin Kendra upgraded Assertio Therapeutics (NASDAQ: ASRT) from Hold to Buy.


For an analyst ratings summary and ratings history on Assertio Therapeutics click here. For more ratings news on Assertio Therapeutics click here.


Shares of Assertio Therapeutics closed at $0.59 yesterday.


You May Also Be Interested In





Related Categories

Upgrades